Skip to content
MRK Merck & Co Inc NYSE
112.52 USD 1.43% +1.59
OPEN 111.11
DAY RANGE 112.73 - 110.72
52 WEEK RANGE 119.65 - 83.05
Interactive Brokers Logotype

Buy MRK stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 285.5B
Enterprise value 301.9B
Trailing pe 21.976562
Forward pe 13.191091
Peg ratio 13.191091
Price to sales ttm 4.933777
Price to book mrq 6.0963316
Enterprise to revenue 5.217
Enterprise to ebitda 13.498


Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.22516
Operating margin 0.32313
Return on assets ttm 0.10899
Return on equity ttm 0.29693002
Income statement
Revenue ttm 57.9B
Revenue per share ttm 22.833
Quarterly revenue growth -0.089
Gross profit ttm 42.1B
Ebitda 16.8B
Net income to common ttm 13B
Diluted eps ttm 5.12
Quarterly earnings growth yoy -0.345
Balance sheet
Total cash mrq 10.4B
Total cash per share mrq 4.094
Total debt mrq 30.7B
Total debt to equity mrq 65.552
Current ratio mrq 1.444
Book value per share mrq 18.457
Cash flow
Operating cash flow ttm 15.7B
Levered free cash flow ttm 9.5B

Stock statistics

Shares outstanding 2.5B
Float shares 2.5B
Avg 10 volume 7.4M
Avg 30 volume 6.5M
Shares short 19.6M
Short ratio 3.27
Short percent of shares outstanding 0.0077
Percent held by insiders 0.00089
Percent held by institutions 0.77431

Stock price summary

Fifty two week low 83.05
Fifty two week high 119.65
Fifty two week change 20.156
Beta 0.355383
Day 50 ma 113.216
Day 200 ma 104.30595

Dividends and splits

Forward annual dividend rate 2.92
Forward annual dividend yield 0.026300002
Trailing annual dividend rate 2.8
Trailing annual dividend yield 0.025241142
5 year average dividend yield 2.9
Payout ratio 0.5547
Dividend date 2023-07-10
Ex dividend date 2023-06-14
Last split factor 1048-for-1000 split
Last split date 2021-06-03

Merck & Co (MRK) company profile

Merck & Co Inc.(NYSE: MRK) is a healthcare company providing health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company operates through the segments of Pharmaceutical and Animal Health segments. Merck & Co also has external partnerships for the development and supply of specific health solutions.